Critical COA Specifications for Tert-Butyl N-[(3S)-Piperidin-3-Yl]Carbamate
- Chiral Integrity: Enantiomeric excess must exceed 98% to ensure downstream API efficacy.
- Industrial Purity: Assay specifications typically require >99.0% purity for GMP-grade production.
- Supply Chain: Verified COAs from a global manufacturer guarantee batch-to-batch consistency.
In the pharmaceutical industry, the reliability of chiral intermediates dictates the success of final Active Pharmaceutical Ingredient (API) synthesis. tert-Butyl N-[(3S)-piperidin-3-yl]carbamate (CAS: 216854-23-8) is a critical building block used extensively in the development of antibacterial agents and other therapeutic compounds. With a molecular formula of C10H20N2O2 and a molecular weight of 200.28 g/mol, this compound requires rigorous quality control. Procurement teams must scrutinize the Certificate of Analysis (COA) to verify that the material meets stringent chemical and stereochemical standards.
As a premier global manufacturer, NINGBO INNO PHARMCHEM CO.,LTD. understands that deviations in purity or chirality can compromise entire production runs. This technical guide outlines the essential parameters found in a compliant COA, ensuring buyers secure material suitable for large-scale manufacturing.
Critical Quality Attributes in Certificate of Analysis (COA)
A robust COA for this intermediate goes beyond simple identity confirmation. It must provide detailed data on physicochemical properties and impurity profiles. The primary identifier often appears under various synonyms in documentation, such as (S)-3-(BOC-Amino)piperidine or (S)-3-N-Boc-Aminopiperidine. Regardless of the nomenclature used on the label, the CAS number 216854-23-8 remains the definitive identifier.
The most critical attribute is the assay value. For high-grade pharmaceutical applications, the content should generally be ≥99.0% as determined by HPLC or GC. Furthermore, the protection group stability is vital. The tert-butoxycarbonyl (Boc) group must remain intact during storage to prevent the formation of the free amine, which can lead to polymerization or unwanted side reactions during subsequent coupling steps. Buyers should also verify that the document lists the specific synthesis route used, as this impacts the impurity profile. Asymmetric synthesis versus resolution of racemates will yield different minor impurities that must be quantified.
Acceptance Criteria for Enantiomeric Purity and Residual Solvents
Chiral purity is non-negotiable for this intermediate. Since the product is the (S)-enantiomer, often referred to technically as (S)-3-(tert-Butoxycarbonylamino)piperidine, the presence of the (R)-enantiomer must be minimized. The COA should explicitly state the enantiomeric excess (ee%) or the percentage of the opposite isomer. Typically, an ee% of ≥98.0% is required to avoid costly purification steps later in the synthesis chain.
Residual solvents are another major compliance area governed by ICH Q3C guidelines. Common solvents used in the manufacturing process, such as dichloromethane, ethanol, or ethyl acetate, must be reported with limits adhering to Class 2 or Class 3 solvent restrictions. Heavy metals and residual catalysts from hydrogenation steps must also be below ppm thresholds.
The following table outlines typical acceptance criteria for industrial purity standards:
| Test Parameter | Acceptance Criteria | Test Method |
|---|---|---|
| Appearance | White to off-white crystalline powder | Visual |
| Assay (Purity) | > 99.0% | HPLC / GC |
| Enantiomeric Purity (ee) | > 98.0% | Chiral HPLC |
| Residual Solvents | Compliant with ICH Q3C | GC-Headspace |
| Heavy Metals | < 10 ppm | ICP-MS |
| Water Content | < 0.5% | Karl Fischer |
When evaluating these specifications, it is essential to cross-reference them with the intended application. For example, when sourcing high-purity tert-Butyl N-[(3S)-piperidin-3-yl]carbamate, buyers should ensure the COA reflects stability data if the material is intended for long-term storage before use.
How to Verify COA Compliance for GMP API Production
Verification of a COA is a multi-step process involving both document review and independent testing. For GMP API production, the supplier must provide a COA that is signed and dated by qualified quality assurance personnel. The document should include batch numbers, manufacturing dates, and retest dates. It is also advisable to request a validation report for the analytical methods used, particularly for chiral separation.
Commercial considerations are equally important. While technical specs are paramount, the bulk price often correlates with the level of quality control invested by the supplier. Lower costs may indicate compromised purification steps or less rigorous testing protocols. A reliable partner will offer transparent pricing structures that reflect the cost of maintaining high industrial purity and regulatory compliance.
Furthermore, the synonym (S)-3-Boc-Aminopiperidine is frequently used in procurement catalogs. Buyers must ensure that the chemical structure matches the CAS number regardless of the trade name used. Discrepancies here can lead to the delivery of the wrong isomer, causing significant production delays.
Strategic Procurement from NINGBO INNO PHARMCHEM CO.,LTD.
Securing a consistent supply of chiral intermediates requires a partnership with a manufacturer capable of scaling production without sacrificing quality. NINGBO INNO PHARMCHEM CO.,LTD. specializes in the production of complex intermediates with a focus on stereochemical integrity. By maintaining strict control over the synthesis route and purification processes, the company ensures that every batch meets the rigorous demands of the global pharmaceutical market.
In conclusion, the COA for (S)-tert-Butyl piperidin-3-ylcarbamate is more than a regulatory formality; it is a guarantee of process safety and product efficacy. By focusing on enantiomeric purity, residual solvent limits, and assay accuracy, procurement managers can mitigate risks associated with API synthesis. Partnering with a verified supplier ensures that the technical specifications on paper match the chemical reality in the reactor.